Gabriella Montes

ID: 1b83a3ed-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Coherus to Acquire Surface Oncology

Big Molecule Watch · June 22, 2023

Celltrion Confirms Bioequivalence For CT-P39 Against Xolair In Interim Results Of Phase 3 Study

Big Molecule Watch · April 17, 2023

Celltrion’s Anticancer Biosimilar Debuts in Japan

Big Molecule Watch · February 1, 2023

Amneal Launches RELEUKO (filgrastim-ayow) in the United States

Big Molecule Watch · November 23, 2022

Request for Comments on USPTO Initiatives To Promote Generic Drug and Biosimilar Competition

Big Molecule Watch · October 25, 2022